Your Search Results

Getting ready for tricuspid TEER: key steps in building a successful programme

14 Feb 2026 – From PCR Tokyo Valves 2026

Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.

Getting ready for tricuspid TEER: key steps in building a successful programme

Patient selection for tricuspid TEER in 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on optimizing patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. It integrates anatomical, haemodynamic, and clinical criteria to identify ideal candidates, explores evolving treatment boundaries between TEER, transcatheter tricuspid valve replacement (TTVR), and medical management, and applies evidence from key trials...

Patient selection for tricuspid TEER in 2026

Procedural optimisation for enhanced acute and long-term outcomes

14 Feb 2026 – From PCR Tokyo Valves 2026

This session emphasizes procedural optimization in TAVI to enhance both acute and long-term outcomes. It highlights critical factors such as valve sizing, expansion, implantation depth, and commissural alignment. Practical techniques for pre- and post-dilatation alongside commissural alignment are demonstrated through real cath lab cases, underscoring their...

Procedural optimisation for enhanced acute and long-term outcomes

TAVI: new evidence and clinical trials

14 Feb 2026 – From PCR Tokyo Valves 2026

This session reviews the latest evidence from head-to-head clinical trials comparing contemporary TAVI devices, including detailed discussions of the LANDMARK and COMPARE trials. It also highlights ongoing and upcoming clinical trials poised to influence guideline recommendations and expand the therapeutic scope of TAVI, providing crucial insights...

Team approach to structural heart disease: how to handle unexpected situations

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the multidisciplinary team approach to managing structural heart disease, focusing on responses to unexpected intraoperative and postoperative situations. It features real-world experiences from a TAVI radiologic technologist, clinical engineer, TEER sonographer, and TEER nurse, emphasizing their respective roles in addressing intraoperative events, sudden...

Team approach to structural heart disease: how to handle unexpected situations

From diagnosis to device: decision-making and planning for mitral valve interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

This session offers a structured approach to mitral TEER, integrating advanced imaging techniques for detailed mitral valve morphology evaluation, procedural planning, and complication prediction. It highlights device selection considerations and emerging technologies to tailor interventions for complex mitral valve disease, supported by multiple case presentations and...

From diagnosis to device: decision-making and planning for mitral valve interventions

Healthcare professionals in the structural heart disease treatment

15 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the essential roles and contributions of various healthcare professionals involved in structural heart disease treatment. It offers insights into the unique responsibilities of medical technologists, nurses, and radiological technologists across preoperative, intraoperative, and postoperative stages, fostering collaboration and sharing practical tips to strengthen...

Healthcare professionals in the structural heart disease treatment

Complications and bailout strategies in transcatheter mitral interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.

Complications and bailout strategies in transcatheter mitral interventions

Transcatheter electrosurgery and leaflet modification of the aortic valve

15 Feb 2026 – From PCR Tokyo Valves 2026

This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...

Transcatheter electrosurgery and leaflet modification of the aortic valve

Opening Ceremony: PCR London Valves 2018

10 Sep 2018 – From PCR London Valves 2018

Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.

Opening Ceremony: PCR London Valves 2018

Closing Ceremony and Highlights of the Course: PCR London Valves 2018

11 Sep 2018 – From PCR London Valves 2018

Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!

Closing Ceremony and Highlights of the Course: PCR London Valves 2018

Complex calcified lesion: LIVE Educational Case from Leipzig Heart Centre - Leipzig, Germany

22 May 2026 – From EuroPCR 2026

This session from Leipzig Heart Centre offers an in-depth exploration of complex calcified coronary lesions. It covers the challenges in managing these lesions, emphasizes effective preparation strategies, and highlights the essential role of intravascular imaging. The session includes patient presentation, detailed imaging analysis, strategic operator planning,...